Hydralazine
DrugBank ID: DB01275
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 0 |
| DL Only | 50 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| malignant hypertensive renal disease | 0.9686 | DL |
| malignant renovascular hypertension | 0.9686 | DL |
| pulmonary hypertension owing to lung disease and/or hypoxia | 0.9670 | DL |
| pulmonary hypertension with unclear multifactorial mechanism | 0.9670 | DL |
| hypertensive disorder | 0.9659 | DL |
| Braddock syndrome | 0.9577 | DL |
| chronic pulmonary heart disease | 0.8829 | DL |
| ocular tuberculosis | 0.5907 | DL |
| anuria | 0.5852 | DL |
| congenital temporomandibular joint ankylosis | 0.5850 | DL |
| polydipsia | 0.5820 | DL |
| obsolete superimposed infection | 0.5737 | DL |
| atrial flutter (disease) | 0.5695 | DL |
| obsolete pathologic fracture | 0.5665 | DL |
| obsolete left bundle branch block | 0.5622 | DL |
| obsolete functional visual loss | 0.5612 | DL |
| sunburn | 0.5603 | DL |
| cholangiocarcinoma, susceptibility to | 0.5556 | DL |
| obsolete breast fibroadenosis | 0.5548 | DL |
| guttate psoriasis | 0.5476 | DL |
| sudden arrhythmia death syndrome | 0.5434 | DL |
| tibial adamantinoma | 0.5339 | DL |
| arteriosclerosis obliterans | 0.5329 | DL |
| conduct disorder | 0.5293 | DL |
| pulmonary valve insufficiency | 0.5266 | DL |
| primary hereditary glaucoma | 0.5245 | DL |
| ergotism | 0.5229 | DL |
| Marin-Amat syndrome | 0.5157 | DL |
| inverse Marcus-Gunn phenomenon | 0.5157 | DL |
| mitral valve stenosis | 0.5154 | DL |
| mitral valve prolapse, myxomatous | 0.5125 | DL |
| congenital cystic eye multiple ocular and intracranial anomalies | 0.5118 | DL |
| urinary tract obstruction | 0.5072 | DL |
| paramedian facial cleft | 0.5060 | DL |
| hypercarotenemia and vitamin A deficiency, autosomal recessive | 0.5041 | DL |
| epidural abscess | 0.5035 | DL |
| digitalis poisoning | 0.5030 | DL |
| muscular disease | 0.5028 | DL |
| spinal chordoma | 0.5026 | DL |
| SELENON-related myopathy | 0.5000 | DL |
| X inactivation, familial skewed | 0.5000 | DL |
| febrile seizures plus, genetic epilepsy with febrile seizures plus | 0.5000 | DL |
| hearing loss with skin disease | 0.5000 | DL |
| hypereosinophilia of undetermined significance | 0.5000 | DL |
| hyperkalemic renal tubular acidosis | 0.5000 | DL |
| hypotonia, congenital nystagmus, ataxia, and abnormal auditory brainstem responses | 0.5000 | DL |
| lymphoma, Hodgkin, X-linked pseudoautosomal | 0.5000 | DL |
| methicillin-resistant staphylococcus aureus infectious disease | 0.5000 | DL |
| pneumoconiosis due to talc | 0.5000 | DL |
| seminal vesicle chronic gonorrhea | 0.5000 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.